These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 11673415)
1. SCA1 molecular genetics: a history of a 13 year collaboration against glutamines. Orr HT; Zoghbi HY Hum Mol Genet; 2001 Oct; 10(20):2307-11. PubMed ID: 11673415 [TBL] [Abstract][Full Text] [Related]
2. Progress in pathogenesis studies of spinocerebellar ataxia type 1. Cummings CJ; Orr HT; Zoghbi HY Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309 [TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151 [TBL] [Abstract][Full Text] [Related]
4. Antisense RNA sequences modulating the ataxin-1 message: molecular model of gene therapy for spinocerebellar ataxia type 1, a dominant-acting unstable trinucleotide repeat disease. Gao Y; Zu T; Low WC; Orr HT; McIvor RS Cell Transplant; 2008; 17(7):723-34. PubMed ID: 19044200 [TBL] [Abstract][Full Text] [Related]
6. No association of the SCA1 (CAG)31 allele with Huntington's disease, myotonic dystrophy type 1 and spinocerebellar ataxia type 3. Hellenbroich Y; Kaulich M; Opitz S; Schwinger E; Zühlke C Psychiatr Genet; 2004 Jun; 14(2):61-3. PubMed ID: 15167689 [TBL] [Abstract][Full Text] [Related]
7. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths. Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837 [TBL] [Abstract][Full Text] [Related]
8. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Chen HK; Fernandez-Funez P; Acevedo SF; Lam YC; Kaytor MD; Fernandez MH; Aitken A; Skoulakis EM; Orr HT; Botas J; Zoghbi HY Cell; 2003 May; 113(4):457-68. PubMed ID: 12757707 [TBL] [Abstract][Full Text] [Related]
9. Imperfect CAG repeats form diverse structures in SCA1 transcripts. Sobczak K; Krzyzosiak WJ J Biol Chem; 2004 Oct; 279(40):41563-72. PubMed ID: 15292212 [TBL] [Abstract][Full Text] [Related]
10. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Watase K; Weeber EJ; Xu B; Antalffy B; Yuva-Paylor L; Hashimoto K; Kano M; Atkinson R; Sun Y; Armstrong DL; Sweatt JD; Orr HT; Paylor R; Zoghbi HY Neuron; 2002 Jun; 34(6):905-19. PubMed ID: 12086639 [TBL] [Abstract][Full Text] [Related]
11. Is the 31 CAG repeat allele of the spinocerebellar ataxia 1 (SCA1) gene locus non-specifically associated with trinucleotide expansion diseases? Savić D; Topisirović I; Keckarević M; Keckarević D; Major T; Culjković B; Stojković O; Rakocević-Stojanović V; Mladenović J; Todorović S; Apostolski S; Romac S Psychiatr Genet; 2001 Dec; 11(4):201-5. PubMed ID: 11807410 [TBL] [Abstract][Full Text] [Related]
12. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. Zoghbi HY; Orr HT J Biol Chem; 2009 Mar; 284(12):7425-9. PubMed ID: 18957430 [TBL] [Abstract][Full Text] [Related]
13. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986 [TBL] [Abstract][Full Text] [Related]
14. Cloning and developmental expression analysis of the murine homolog of the spinocerebellar ataxia type 1 gene (Sca1). Banfi S; Servadio A; Chung M; Capozzoli F; Duvick LA; Elde R; Zoghbi HY; Orr HT Hum Mol Genet; 1996 Jan; 5(1):33-40. PubMed ID: 8789437 [TBL] [Abstract][Full Text] [Related]
15. [Analysis and application of SCA1 and SCA3/MJD gene CAG repeats in Han population in Northeastern China]. Jiang M; Jin CL; Lin CK; Qiu GR; Liu ZL; Wang CX; Sun KL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):83-5. PubMed ID: 14767919 [TBL] [Abstract][Full Text] [Related]
16. Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1. Ju H; Kokubu H; Lim J Mol Neurobiol; 2014 Dec; 50(3):866-874. PubMed ID: 24752589 [TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of spinocerebellar ataxia type 1 disease. Kang S; Hong S Mol Cells; 2009 Jun; 27(6):621-7. PubMed ID: 19572115 [TBL] [Abstract][Full Text] [Related]
18. [The clinical features and gene mutation analysis in a pedigree of spinocerebellar ataxia type 7]. Yin XZ; Zhang BR; Wu DW; Tian J; Zhang H Yi Chuan; 2007 Jun; 29(6):688-92. PubMed ID: 17650485 [TBL] [Abstract][Full Text] [Related]
19. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice. Clark HB; Orr HT J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181 [TBL] [Abstract][Full Text] [Related]
20. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. Zu T; Duvick LA; Kaytor MD; Berlinger MS; Zoghbi HY; Clark HB; Orr HT J Neurosci; 2004 Oct; 24(40):8853-61. PubMed ID: 15470152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]